Catena Biosciences, a pioneering biotech company founded in 2020, has successfully raised $2,350,000 in its latest funding round, a significant endorsement of its innovative approach in the field of life sciences. Built upon groundbreaking technology developed in the esteemed Francis and Doudna Labs at UC Berkeley, CatenaBio leverages a unique platform that enables the rapid coupling of proteins to create novel therapeutics. With a focus on oncology, autoimmune disorders, and vaccine development, the company is driven by a mission to address some of the most pressing healthcare challenges of our time. This new capital will accelerate CatenaBio's research and development efforts, allowing the team to expand its pipeline of therapeutic candidates while scaling its operations to meet the growing demand within these critical areas. “We are thrilled with the confidence our investors have shown in us and excited about the potential impact our technology can have in the medical field,” said Dr. **[CEO or founder's name]**, the CEO of CatenaBio. The funding will not only enhance their ability to innovate but also support the collaboration with research institutions and pharmaceutical companies to bring transformative therapies to patients faster than ever before. Join us in following our journey as we strive to revolutionize the therapeutic landscape and truly make a difference in people's lives. For more information about Catena Biosciences and our future initiatives, visit www.catenabiosciences.com.
CatenaBio Secures $2.35M in Seed Funding to Accelerate Breakthrough Therapeutics Development
Recently funded · $2.4M SeedBiotechnology
Get the full CatenaBio company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Eternal Forest
The world where forests are appreciated as living beings for their beauty, deep connection, biodiversity and peace! Today, old-growth forests are few; many people have never experienced the awe of being in the presence of a 1,000-year-old being. This vision makes this experience possible for those who come after us. It is an invitation to become part of history, by co-creating a new kind of ecological artwork – establishing an Eternal Forest Sanctuary for 1,000 years.
$6.7K Crowdfunding
today
Cyclops
Cyclops enables payments companies to onboard with a single partner, unlocking stablecoin settlement, payins, payouts and treasury optimization across global corridors - all through a single API. Cyclops was founded by payments executives and crypto veterans who were fed up with stablecoin fragmentation. The first complete stablecoin platform built exclusively for the payments industry, Cyclops combines the agility of orchestration with the comprehensive build outs of full-stack providers. Cyclops has end-to-end integrations to every leading provider at every layer of the stablecoin stack, and proprietary technology built on top to make payments use cases effortless. With this unique approach, Cyclops is the only platform offering product and license redundancy in all major markets, with dozens of partners and over 100 global licenses.
Other recent Seed rounds
Companies that recently closed a Seed round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Mission Control Data for Good The Netherlands | Seed | $120.0K | today |
| 2 |  Bot-Hive United Kingdom | Seed | $311.0K | today |
